Axcelis Technologies, Inc.

NASDAQ•ACLS

CEO: Dr. Russell J. Low Ph.D.

Sector: Technology

Industry: Semiconductors

Listing Date: 2000-07-11

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Japan, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

Contact Information

108 Cherry Hill Drive, Beverly, MA, 01915-1088, United States

978-787-4000

www.axcelis.com

Market Cap

$2.65B

P/E (TTM)

22.2

48.2

Dividend Yield

52W High

$102.93

52W Low

$40.40

52W Range

73%

Rank43Top 50.7%

3.8

F-Score

Modified Piotroski Analysis

Based on 10-year fundamentals

Weak • 3.8 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$238.33M+0.00%

4-Quarter Trend

EPS

$1.11+0.00%

4-Quarter Trend

FCF

-$8.90M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Gross Margin Stability Maintained Total revenue fell 17.6% to $839.0M; however, gross margin slightly increased to 44.9% from 44.7%.

Aftermarket Revenue Growth Services revenue increased 14.7% to $47.0M in 2025, showing resilience against system sales decline.

Power Device Segment Focus Technology leadership maintained in implant-intensive power device segment, representing 55% of 2025 system shipments.

2025 Diluted Earnings Per Share Diluted earnings per share reached $3.80 for fiscal year 2025, compared to $6.15 reported in 2024.

Risk Factors

Significant Revenue Contraction Total revenue dropped 17.6% to $839.0M in 2025, driven by decreased Purion system sales volume.

Increased Customer Concentration Top ten customers accounted for 55.2% of net sales in 2025, increasing risk from customer loss.

International Sales Exposure Substantial revenue derived internationally (83.7% in 2025), especially Asia (76.0% of system revenue), facing trade tensions.

Rising Operating Expenses Operating expenses grew 5.6% to $257.5M; R&D spending rose to 13.0% of revenue.

Outlook

2026 CS&I Revenue Target Strategic goal targets CS&I aftermarket revenue to reach approximately 25% of total revenues by 2026.

Veeco Merger Completion Expected Merger with Veeco remains subject to regulatory approval, expected completion in the second half of 2026.

Focus on Customer Solutions Continued investment in CS&I aftermarket business to drive financial growth and enhance customer satisfaction levels.

Long-Term Implant Foundation Strategy focuses on building foundation on long-term implant-only business model while expanding advanced logic footprint.

Peer Comparison

Revenue (TTM)

CNXC

$9.83B

+2.2%

VSH

$3.07B

+4.5%

GLOB

$2.45B

+1.6%

Gross Margin (Latest Quarter)

ALRM

62.7%

+25.8pp

POWI

52.9%

+0.0pp

SIMO

49.1%

+1.9pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
SIMO	$4.15B	8.5	15.2%	0.0%
ACMR	$3.15B	33.1	7.8%	10.5%
SYNA	$2.99B	-48.2	-4.4%	32.6%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

7.4%

Steady Growth

4Q Net Income CAGR

6.3%

Profitability Improving

Cash Flow Stability

75%

Volatile Cash Flow

Deep Research

Next earnings:May 4, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data